Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ARA NYSE:FEO CVE:GQC NASDAQ:REG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARAAmerican Renal Associates$11.52$11.50$5.57▼$11.98$397.94M1.11106,940 shs9,831 shsFEOFirst Trust/abrdn Emerging Opportunity Fund$9.58$9.40$8.35▼$14.16N/AN/A27,706 shs150,253 shsGQCGoldquest MiningC$0.81+1.3%C$0.69C$0.16▼C$0.87C$276.23M0.479812113,991 shs255,981 shsREGRegency Centers$70.32-0.1%$71.47$63.44▼$78.18$12.78B1.091.10 million shs292,368 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARAAmerican Renal Associates0.00%0.00%0.00%0.00%0.00%FEOFirst Trust/abrdn Emerging Opportunity Fund0.00%0.00%0.00%0.00%0.00%GQCGoldquest Mining+5.26%+14.29%+17.65%-6.98%+220.00%REGRegency Centers-0.83%-2.78%-0.90%-0.48%-5.87%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARAAmerican Renal Associates$11.52$11.50$5.57▼$11.98$397.94M1.11106,940 shs9,831 shsFEOFirst Trust/abrdn Emerging Opportunity Fund$9.58$9.40$8.35▼$14.16N/AN/A27,706 shs150,253 shsGQCGoldquest MiningC$0.81+1.3%C$0.69C$0.16▼C$0.87C$276.23M0.479812113,991 shs255,981 shsREGRegency Centers$70.32-0.1%$71.47$63.44▼$78.18$12.78B1.091.10 million shs292,368 shs10 Best Stocks to Own: Fall 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARAAmerican Renal Associates0.00%0.00%0.00%0.00%0.00%FEOFirst Trust/abrdn Emerging Opportunity Fund0.00%0.00%0.00%0.00%0.00%GQCGoldquest Mining+5.26%+14.29%+17.65%-6.98%+220.00%REGRegency Centers-0.83%-2.78%-0.90%-0.48%-5.87%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARAAmerican Renal Associates 0.00N/AN/AN/AFEOFirst Trust/abrdn Emerging Opportunity Fund 0.00N/AN/AN/AGQCGoldquest Mining 0.00N/AN/AN/AREGRegency Centers 2.67Moderate Buy$78.4211.52% UpsideCurrent Analyst Ratings BreakdownLatest FEO, ARA, REG, and GQC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/15/2025REGRegency CentersEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetIn-Line$76.00 ➝ $77.009/9/2025REGRegency CentersLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral$76.008/28/2025REGRegency CentersScotiabankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Perform$75.00 ➝ $76.008/27/2025REGRegency CentersBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$77.00 ➝ $79.008/27/2025REGRegency CentersWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$79.00 ➝ $81.008/20/2025REGRegency CentersMizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$74.00 ➝ $77.008/15/2025REGRegency CentersTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$79.00 ➝ $81.007/30/2025REGRegency CentersRobert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$78.00 ➝ $80.007/30/2025REGRegency CentersEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetIn-Line$79.00 ➝ $80.007/17/2025REGRegency CentersMizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$79.00 ➝ $74.00(Data available from 9/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARAAmerican Renal Associates$822.52M0.48$1.69 per share6.80$2.59 per share4.45FEOFirst Trust/abrdn Emerging Opportunity FundN/AN/AN/AN/AN/AN/AGQCGoldquest MiningN/AN/AC$0.26 per share3.06C$0.03 per shareN/AREGRegency Centers$1.45B8.78$4.29 per share16.40$36.78 per share1.91Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARAAmerican Renal Associates-$13.79M$0.26N/AN/AN/A-2.04%-3.56%-0.24%N/AFEOFirst Trust/abrdn Emerging Opportunity FundN/AN/A0.00∞N/AN/AN/AN/AN/AGQCGoldquest Mining-C$2.74M-C$0.01N/A∞N/AN/A-27.38%-17.22%N/AREGRegency Centers$400.39M$2.1432.9015.063.0727.00%6.05%3.22%10/28/2025 (Estimated)Latest FEO, ARA, REG, and GQC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/29/2025Q2 2025REGRegency Centers$1.12$1.16+$0.04$1.16$366.35 million$369.85 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARAAmerican Renal AssociatesN/AN/AN/AN/AN/AFEOFirst Trust/abrdn Emerging Opportunity Fund$1.4014.61%N/AN/AN/AGQCGoldquest MiningN/AN/AN/AN/AN/AREGRegency Centers$2.824.01%N/A131.78%5 YearsLatest FEO, ARA, REG, and GQC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/5/2025REGRegency Centersquarterly$0.70503.9%9/11/20259/11/202510/2/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARAAmerican Renal Associates7.541.051.02FEOFirst Trust/abrdn Emerging Opportunity FundN/AN/AN/AGQCGoldquest MiningN/A28.9867.24REGRegency Centers0.721.131.13Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARAAmerican Renal Associates78.42%FEOFirst Trust/abrdn Emerging Opportunity FundN/AGQCGoldquest Mining6.77%REGRegency Centers96.07%Insider OwnershipCompanyInsider OwnershipARAAmerican Renal Associates9.50%FEOFirst Trust/abrdn Emerging Opportunity FundN/AGQCGoldquest Mining17.36%REGRegency Centers1.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARAAmerican Renal Associates4,97734.54 millionN/AOptionableFEOFirst Trust/abrdn Emerging Opportunity FundN/AN/AN/ANot OptionableGQCGoldquest MiningN/A341.02 millionN/ANot OptionableREGRegency Centers440181.55 million179.74 millionOptionableFEO, ARA, REG, and GQC HeadlinesRecent News About These CompaniesVoya Investment Management LLC Cuts Position in Regency Centers Corporation $REGSeptember 17 at 3:26 AM | marketbeat.comEvercore ISI Forecasts Strong Price Appreciation for Regency Centers (NASDAQ:REG) StockSeptember 17 at 2:39 AM | americanbankingnews.comRegency Centers (NASDAQ:REG) Stock Price Expected to Rise, Evercore ISI Analyst SaysSeptember 16 at 10:22 AM | marketbeat.comStrs Ohio Invests $5.50 Million in Regency Centers Corporation $REGSeptember 16 at 3:38 AM | marketbeat.comMuch-anticipated Cheshire retail center, soon home to Whole Foods and Shake Shack, sets grand opening dateSeptember 15 at 2:41 PM | registercitizen.comRIs Regency Centers Attractively Priced After Recent Retail Leasing Momentum in 2025?September 15 at 9:41 AM | finance.yahoo.comInvst LLC Invests $749,000 in Regency Centers Corporation $REGSeptember 15 at 5:09 AM | marketbeat.comBROOKFIELD Corp ON Decreases Stock Holdings in Regency Centers Corporation $REGSeptember 14 at 6:25 AM | marketbeat.comRegency Centers Corporation $REG Position Cut by Nicola Wealth Management LTD.September 14 at 6:15 AM | marketbeat.comIntrua Financial LLC Invests $460,000 in Regency Centers Corporation $REGSeptember 14 at 5:15 AM | marketbeat.comIFM Investors Pty Ltd Lowers Holdings in Regency Centers Corporation $REGSeptember 14 at 4:46 AM | marketbeat.comUBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $167.60 Million Stock Position in Regency Centers Corporation $REGSeptember 14 at 4:19 AM | marketbeat.comAscent Group LLC Buys Shares of 3,505 Regency Centers Corporation $REGSeptember 14 at 4:03 AM | marketbeat.comRegency Centers Corporation $REG Shares Sold by Royal Bank of CanadaSeptember 14 at 3:03 AM | marketbeat.comMillennium Management LLC Has $30.96 Million Holdings in Regency Centers Corporation $REGSeptember 13, 2025 | marketbeat.comSCS Capital Management LLC Invests $2.14 Million in Regency Centers Corporation $REGSeptember 12, 2025 | marketbeat.comWoodline Partners LP Buys 407,865 Shares of Regency Centers Corporation $REGSeptember 12, 2025 | marketbeat.comMBB Public Markets I LLC Buys Shares of 4,272 Regency Centers Corporation $REGSeptember 12, 2025 | marketbeat.comRyanwood Square, along S.R. 60 in Indian River County, to undergo exterior constructionSeptember 11, 2025 | msn.comRegency Centers (NASDAQ:REG) Now Covered by Analysts at LADENBURG THALM/SH SHSeptember 11, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Buys 21,029 Shares of Regency Centers Corporation $REGSeptember 11, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesGrab Holdings: Get a Grip Now—Explosive Upside Brewing By Thomas Hughes | August 18, 2025The Most Beloved American-Made Products in Every State [2025 Survey]By MarketBeat Staff | August 28, 2025Is Paramount Skydance a Buy Post-Merger, Short Squeeze?By Leo Miller | August 24, 2025These 3 Chinese Stocks Could Be a Ticking Time Bomb of GrowthBy Gabriel Osorio-Mazilli | August 26, 2025Which States Have the Highest Interest Rates on Family Loans? [2025 Survey]By MarketBeat Staff | August 25, 2025FEO, ARA, REG, and GQC Company DescriptionsAmerican Renal Associates NYSE:ARAAmerican Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.First Trust/abrdn Emerging Opportunity Fund NYSE:FEOFirst Trust-abrdn Emerging Opportunity Fund is a closed-ended balanced mutual fund launched and managed by First Trust Advisors L.P. It is co-managed by Aberdeen Asset Management Inc. The fund invests in public equity and fixed income markets of global emerging countries. It seeks to invest in the stocks of companies operating across the diversified sectors. For its fixed income component, the fund invests in government debt securities, corporate bonds, non investment-grade securities, asset-backed securities, credit-linked notes, and credit default swaps. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the Barclays Capital Global Emerging Markets Index, FTSE All World Emerging Market Index, and a blended index composed of JPMorgan Emerging Markets Bond Index - Global Diversified (32.5%); JPMorgan Government Bond Index - Emerging Markets (32.5%); MSCI Global Emerging Markets Index (35.0%). First Trust-abrdn Emerging Opportunity Fund was formed on August 28, 2006 and is domiciled in the United States.Goldquest Mining CVE:GQCC$0.81 +0.01 (+1.25%) As of 01:59 PM EasternGoldquest Mining Corp., together with its subsidiaries, engages in the identification, acquisition, and exploration of mineral properties in the Dominican Republic. The company primarily explores for gold and copper deposits. It primarily owns a 100% interest in the Romero gold-copper project that comprises two mineral deposits covering an area of 3,997 hectares located to the south of the Central Cordillera of Hispaniola; and the Tireo property comprising 13 concessions covering an area of 20,076 hectares located in the province of San Juan de la Maguana, the Dominican Republic. Goldquest Mining Corp. was incorporated in 1989 and is headquartered in Santo Domingo, the Dominican Republic.Regency Centers NASDAQ:REG$70.32 -0.06 (-0.09%) As of 02:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Regency Centers is a preeminent national owner, operator, and developer of shopping centers located in suburban trade areas with compelling demographics. Our portfolio includes thriving properties merchandised with highly productive grocers, restaurants, service providers, and best-in-class retailers that connect to their neighborhoods, communities, and customers. Operating as a fully integrated real estate company, Regency Centers is a qualified real estate investment trust (REIT) that is self-administered, self-managed, and an S&P 500 Index member. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom Hits Record High After CEO Hock Tan AI Pay Package CrowdStrike Stock Set for Breakout as Agentic AI Demand Surges Why CoreWeave's NVIDIA Deal Creates a Deep Moat for AI Investors Resideo Technologies: Institutional Activity Signals 30% Upside This Stock Quietly Benefits From Oracle and NVIDIA’s AI Surge Rezolute Stock: FDA Fast Track Fuels 2025 Breakout Lululemon’s Sell-Off Looks Overdone: A Contrarian Case This Defense Stock Is Up 113% This Year—Is It Still a Buy? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
